Severe Bradycardia Leading to Hemodynamic Instability Associated with Remdesivir Use in a Patient with COVID-19 Pneumonia
Remdesivir (RDV) is an approved treatment for hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. There is limited literature on the cardiac adverse effects of RDV. We report a case of a patient who developed hemodynamically unstable bradycardia after t...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Case Reports in Critical Care |
Online Access: | http://dx.doi.org/10.1155/2022/8807957 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832562423705370624 |
---|---|
author | Bhargavi Donepudi Shikhar Agarwal Lokendra Thakur |
author_facet | Bhargavi Donepudi Shikhar Agarwal Lokendra Thakur |
author_sort | Bhargavi Donepudi |
collection | DOAJ |
description | Remdesivir (RDV) is an approved treatment for hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. There is limited literature on the cardiac adverse effects of RDV. We report a case of a patient who developed hemodynamically unstable bradycardia after the initiation of RDV that resolved after discontinuing RDV. |
format | Article |
id | doaj-art-ae3c597040a0426ba3290419c074ef5b |
institution | Kabale University |
issn | 2090-6439 |
language | English |
publishDate | 2022-01-01 |
publisher | Wiley |
record_format | Article |
series | Case Reports in Critical Care |
spelling | doaj-art-ae3c597040a0426ba3290419c074ef5b2025-02-03T01:22:40ZengWileyCase Reports in Critical Care2090-64392022-01-01202210.1155/2022/8807957Severe Bradycardia Leading to Hemodynamic Instability Associated with Remdesivir Use in a Patient with COVID-19 PneumoniaBhargavi Donepudi0Shikhar Agarwal1Lokendra Thakur2Department of Critical Care MedicineDepartment of CardiologyDepartment of Critical Care MedicineRemdesivir (RDV) is an approved treatment for hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. There is limited literature on the cardiac adverse effects of RDV. We report a case of a patient who developed hemodynamically unstable bradycardia after the initiation of RDV that resolved after discontinuing RDV.http://dx.doi.org/10.1155/2022/8807957 |
spellingShingle | Bhargavi Donepudi Shikhar Agarwal Lokendra Thakur Severe Bradycardia Leading to Hemodynamic Instability Associated with Remdesivir Use in a Patient with COVID-19 Pneumonia Case Reports in Critical Care |
title | Severe Bradycardia Leading to Hemodynamic Instability Associated with Remdesivir Use in a Patient with COVID-19 Pneumonia |
title_full | Severe Bradycardia Leading to Hemodynamic Instability Associated with Remdesivir Use in a Patient with COVID-19 Pneumonia |
title_fullStr | Severe Bradycardia Leading to Hemodynamic Instability Associated with Remdesivir Use in a Patient with COVID-19 Pneumonia |
title_full_unstemmed | Severe Bradycardia Leading to Hemodynamic Instability Associated with Remdesivir Use in a Patient with COVID-19 Pneumonia |
title_short | Severe Bradycardia Leading to Hemodynamic Instability Associated with Remdesivir Use in a Patient with COVID-19 Pneumonia |
title_sort | severe bradycardia leading to hemodynamic instability associated with remdesivir use in a patient with covid 19 pneumonia |
url | http://dx.doi.org/10.1155/2022/8807957 |
work_keys_str_mv | AT bhargavidonepudi severebradycardialeadingtohemodynamicinstabilityassociatedwithremdesiviruseinapatientwithcovid19pneumonia AT shikharagarwal severebradycardialeadingtohemodynamicinstabilityassociatedwithremdesiviruseinapatientwithcovid19pneumonia AT lokendrathakur severebradycardialeadingtohemodynamicinstabilityassociatedwithremdesiviruseinapatientwithcovid19pneumonia |